Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
暂无分享,去创建一个
E. Swisher | H. Gray | K. Doll | S. Jorge | S. Masshoor
[1] B. Bierer,et al. Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov , 2021, PLoS medicine.
[2] Kevin Hur,et al. Association Between Limited English Proficiency and Healthcare Access and Utilization in California , 2021, Journal of Immigrant and Minority Health.
[3] A. Kurian,et al. Limited English Proficiency and Disparities in Health Care Engagement Among Patients With Breast Cancer , 2021, JCO oncology practice.
[4] K. Lapane,et al. The Role of Limited English Proficiency and Access to Health Insurance and Health Care in the Affordable Care Act Era , 2020, Health equity.
[5] J. Pierce,et al. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity. , 2020, Gynecologic oncology.
[6] N. Gusani,et al. Clinical Trial Accrual at Initial Course of Therapy for Cancer and Its Impact on Survival. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] G. Tomlinson,et al. Association Between Limited English Proficiency and Revisits and Readmissions After Hospitalization for Patients With Acute and Chronic Conditions in Toronto, Ontario, Canada. , 2019, JAMA.
[8] T. Owonikoko,et al. Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy. , 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[9] B. Karlan,et al. Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients , 2018, Applied Cancer Research.
[10] S. Temkin,et al. A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review. , 2018, Gynecologic oncology.
[11] A. Girgis,et al. Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers , 2018, Asia-Pacific journal of clinical oncology.
[12] M. Leblanc,et al. The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population , 2017, JAMA oncology.
[13] Melissa M. Parker,et al. Association of Patient-Physician Language Concordance and Glycemic Control for Limited–English Proficiency Latinos With Type 2 Diabetes , 2017, JAMA internal medicine.
[14] Eun Ji Kim,et al. Disparities in Hypertension Associated with Limited English Proficiency , 2017, Journal of General Internal Medicine.
[15] E. Kohn,et al. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies. , 2016, Gynecologic oncology.
[16] H. Lankes,et al. Minority participation in Gynecologic Oncology Group (GOG) Studies. , 2014, Gynecologic oncology.
[17] Diane P. Martin,et al. Comparison of survival outcomes among cancer patients treated in and out of clinical trials. , 2014, Journal of the National Cancer Institute.
[18] W. Al-Refaie,et al. Does enrollment in cancer trials improve survival? , 2013, Journal of the American College of Surgeons.
[19] N. Bjarnason. Disparities in participation in cancer clinical trials. , 2004, JAMA.
[20] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[21] M. Christian,et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Mansfield,et al. Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years. , 2018, Journal of oncology practice.
[23] A. Bleyer,et al. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[24] PhD Daniel Goldberg JD. The case for eliminating disparities in clinical trials , 2010, Journal of Cancer Education.
[25] Mph Garth Graham MD,et al. Addressing disparities in clinical trials: Culturally and linguistically appropriate standards in clinical trials (CLAS-ACT) and the EDICT backpack initiative , 2009, Journal of Cancer Education.